News

Silexion Therapeutics Corp: Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech company developing RNA interference (RNAi) ...
The Manila Times1d
KD Hall Foundation Marks 10 Years of Impact with "We Have Risen” Celebration Honoring Women, Girls, and the Power of Storytelling
SEATTLE, WA - May 12, 2025 - The KD Hall Foundation, a Washington-based nonprofit advancing leadership, education, and mental health for women and girls, will celebrate 10 years of transformative ...
Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Significant advancements in preclinical pipeline for SIL204, with groundbreaking data demonstrating efficacy against both ...